0000899243-20-030841.txt : 20201112
0000899243-20-030841.hdr.sgml : 20201112
20201112171338
ACCESSION NUMBER: 0000899243-20-030841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201110
FILED AS OF DATE: 20201112
DATE AS OF CHANGE: 20201112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colabuono Peter
CENTRAL INDEX KEY: 0001819620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39425
FILM NUMBER: 201307968
MAIL ADDRESS:
STREET 1: C/O DECHENG CAPITAL
STREET 2: 3000 SAND HILL ROAD, BUILDING 2, STE 110
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001651431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364813934
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 978-503-2124
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-10
0
0001651431
Checkmate Pharmaceuticals, Inc.
CMPI
0001819620
Colabuono Peter
C/O CHECKMATE PHARMACEUTICALS, INC.
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
10.95
2020-11-10
4
A
0
20000
0.00
A
2030-11-09
Common Stock
20000
20000
D
33.3% of the shares subject to such option vest and become exercisable on August 6, 2021 and the remainder of the shares vest in substantially equal monthly installments for a period of 24 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Kleem Chaudhary, attorney-in-fact
2020-11-12